We use cookies to understand how you use our site and to improve your experience. By clicking “Got it” or by continuing to use our website you agree to their use. More info
Got it

Asian stocks gain as upbeat China data lifts mood

    Eden 2020-09-15 16:26:16

    By Anshuman Daga

    SINGAPORE (Reuters) - Asian equities advanced on Tuesday and the dollar slipped, with investor sentiment supported by Chinese data and optimism about COVID-19 vaccines.

    MSCI's broadest index of Asia-Pacific shares outside Japan rose 0.5%, for a fourth straight day of gains, up nearly 3% so far this year.

    E-Mini futures for the S&P 500 put on 0.2%, reversing early losses, while EUROSTOXX 50 futures eased 0.2%.

    Chinese blue chips added 0.7%, buoyed by data showing China's industrial output rose 5.6% in August from a year ago, expanding for a fifth straight month. The yuan climbed to a 16-month high. [B9N2F802B]

    "The activity data today shows that the recovery in the private sector gained momentum in August. The recovery in China has become more balanced and broad-based," HSBC economists said in a report.

    Japan's Nikkei shed 0.5%, while South Korean shares were 0.5% higher and Australia's S&P/ASX 200 index eased 0.2%.

    Japanese Chief Cabinet Secretary Yoshihide Suga won a ruling party leadership vote, paving the way for Japan's first change of leader in nearly eight years.

    Strategists expect Japanese equities to take support from Suga's win.

    "He's seen as someone who's particularly stock market friendly. The fact that we've got political certainty for the next two years from someone who's connected to the free market is going to be good news for Japan," said Jim McCafferty, joint head of Asia Pacific equity research at Nomura.

    E-Mini futures for the S&P 500 slipped 0.3%, while EUROSTOXX 50 futures eased 0.2%

    So far this year, gains in Asia have been led by technology stocks.

    "From an asset class point of view, if you require to generate any income from your investment portfolio, then equities is one of the few places you can do that because bond yields are so low," said McCafferty, who prefers North Asian companies due to their stronger balance sheets.

    He said investors who didn't want to pay lofty valuations of U.S. stocks could look to fast-growing tech companies in Taiwan and South Korea.

    U.S. retail sales figures from August are due Wednesday.

    Investors will also look to central banks for direction, with the U.S. Federal Reserve starting a two-day policy meeting on Tuesday, the first since unveiling a landmark shift to a more tolerant stance on inflation in August.

    The Bank of Japan and the Bank of England announce their respective policy decisions on Thursday.

    Markets will be focused on projections from Fed policymakers on the U.S. growth outlook and on any details about what the bank intends to do to encourage inflation.

    The Dow Jones Industrial Average closed up 1.2% and the S&P 500 rose 1.3% while the tech-heavy Nasdaq Composite added 1.9%.

    "We remain neutral stocks versus bonds as we balance extended equity valuations, fading fiscal support, and upcoming U.S. election risks against still ultra-low interest rates and a gradually improving economic environment," analysts at T. Rowe Price said in a global asset allocation report.

    U.S. stocks gained after drugmaker AstraZeneca (NYSE:AZN) said it resumed its British clinical trials of its COVID-19 vaccine, one of the most advanced in development.

    The dollar index slipped to 93.029, dipping further from a one-month high of 93.664 touched last week. The euro ticked up to $1.1867, having gained for four straight sessions until Monday.

    Against the safe-haven yen, the dollar traded at 105.73 yen, having touched a two-week low of 105.55 yen on Monday.

    Brent crude was down 0.2%, at $39.5, reversing earlier gains. U.S. West Texas Intermediate (WTI) crude futures were down 0.1% at $37.2 a barrel.

    Gold prices put on 0.6%, extending a sharp rise in the previous session.

    6 Reasons To Open An Account

    Multi-language 24/7 professional support

    Fast, convenient fund and withdrawals

    Free demo account $10,000

    International recognition

    Real-time quotes with push notification

    Professional market analysis broadcast

    24/7 Support

    Need Help?
    24/7 Support
    Scroll to Top
    Risk Warning | Remember that CFDs are a leveraged product and can result in the loss of your entire capital. Trading CFDs may not be suitable for you. Please ensure you fully understand the risks involved. Please consider our User Agreement, Risk Warning and Summary Order Execution Policy before using our services. CFD traders do not own or have any rights to the underlying assets.

    TOP 1 MARKETS does not issue advice, recommendations or opinion in relation to acquiring, holding or disposing of our products.
    All of our products are over-the-counter derivatives over global underlying assets. TOP 1 MARKETS provide execution only service, acting as principle at all times.
    TOP 1 MARKETS does not issue, buy or sell any cryptocurrencies nor is it a cryptocurrency exchange.

    This website is owned and operated by TOP 1 MARKETS PTY LTD(ABN:61 631 331 854). TOP 1 MARKETS PTY LTD is authorized by the Australian Securities and Investment Commission(AFSL:001276870).
    The information on this website is not intended for residents of the United States, Singapore, Hong Kong, Belgium, Iran, and North Korea; and is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
    TOP1 Group is registered in the Cayman Islands, address: 3th Floor Ellen Skelton Building 3076 Sir Francis Drake Highway Road Town, Tortola British Virgin Islands VG1110.
    It operates through the following two subsidiaries: TOP 1 MARKETS PTY LTD and Top 1 Markets Limited.
    Join our community:
    © 2019 Top1Markets Copyright